Somatic variants in the Kirsten rat sarcoma virus oncogene homolog (<i>KRAS</i>) gene have a significant influence on CRC progression and serve as key predictors of resistance to anti-epidermal growth factor receptor (EGFR) therapy. The gene discussed is KRAS; the disease is colorectal carcinoma.